Controlled spatial and conformational display of immobilised bone morphogenetic protein-2 and osteopontin signalling motifs regulates osteoblast adhesion and differentiation in vitro

BMC Biology

Volumn 8, Issue , 2010, Pages

  Mitchell, Elizabeth A ^a   Chaffey, Benjamin T ^a   McCaskie, Andrew W ^a   Lakey, Jeremy H ^a   Birch, Mark A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIA;

BONE MORPHOGENETIC PROTEIN 2; GOLD; HYBRID PROTEIN; LIGAND; OSTEOPONTIN;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CHEMICAL STRUCTURE; ESCHERICHIA COLI; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; IN VITRO STUDY; METABOLISM; METHODOLOGY; OSTEOBLAST; PHYSIOLOGY; PROTEIN ENGINEERING;

ANALYSIS OF VARIANCE; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CELL ADHESION; CELL DIFFERENTIATION; ESCHERICHIA COLI; FLUORESCENT ANTIBODY TECHNIQUE; GOLD; LIGANDS; MODELS, MOLECULAR; OSTEOBLASTS; OSTEOPONTIN; PROTEIN ENGINEERING; RECOMBINANT FUSION PROTEINS;

EID: 77951954578     PISSN: None     EISSN: 17417007     Source Type: Journal    
DOI: 10.1186/1741-7007-8-57     Document Type: Article

References (44)

1. Daley WP, Peters SB, Larsen M. Extracellular matrix dynamics in development and regenerative medicine. J Cell Sci 2008, 121:255-264. 10.1242/jcs.006064, 18216330.
2. Pierschbacher MD, Ruoslahti E. Variants of the cell recognition site of fibronectin that retain attachment-promoting activity. Proc Natl Acad Sci USA 1984, 81:5985-5988. 10.1073/pnas.81.19.5985, 391843, 6237366.
3. Humphries MJ, Obara M, Olden K, Yamada KM. Role of fibronectin in adhesion, migration, and metastasis. Cancer Invest 1989, 7:373-393. 10.3109/07357908909039866, 2531625.
4. Garamszegi N, Garamszegi SP, Shehadeh LA, Scully SP. Extracellular matrix-induced gene expression in human breast cancer cells. Mol Cancer Res 2009, 7:319-329. 10.1158/1541-7786.MCR-08-0227, 2681181, 19276183.
5. Sahni A, Sporn LA, Francis CW. Potentiation of endothelial cell proliferation by fibrin(ogen)-bound fibroblast growth factor-2. J Biol Chem 1999, 274:14936-14941. 10.1074/jbc.274.21.14936, 10329694.
6. Ehrbar M, Metters A, Zammaretti P, Hubbell JA, Zisch AH. Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity. J Control Release 2005, 101:93-109. 10.1016/j.jconrel.2004.07.018, 15588897.
7. Sahni A, Guo M, Sahni SK, Francis CW. Interleukin-1beta but not IL-1alpha binds to fibrinogen and fibrin and has enhanced activity in the bound form. Blood 2004, 104:409-414. 10.1182/blood-2004-01-0126, 15039285.
8. Chaffey BT, Mitchell E, Birch MA, Lakey JH. A generic expression system to produce proteins that co-assemble with alkane thiol SAM. Int J Nanomedicine 2008, 3:287-93. 2626940, 18990938.
9. Shah DS, Thomas MB, Phillips S, Cisneros DA, Le Brun AP, Holt SA, Lakey JH. Self-assembling layers created by membrane proteins on gold. Biochem Soc Trans 2007, 35:522-526. 10.1042/BST0350522, 17511643.
10. Anderluh G, Gokce I, Lakey JH. Expression of proteins using the third domain of the Escherichia coli periplasmic-protein TolA as a fusion partner. Protein Expr Purif 2003, 28:173-181. 10.1016/S1046-5928(02)00681-2, 12651122.
11. Yokosaki Y, Matsuura N, Sasaki T, Murakami I, Schneider H, Higashiyama S, Saitoh Y, Yamakido M, Taooka Y, Sheppard D. The Integrin α9β1 bind to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin. J Biol Chem 1999, 274:36328-36334. 10.1074/jbc.274.51.36328, 10593924.
12. Hamada Y, Nokihara K, Okazaki M, Fujitani W, Matsumoto T, Matsuo M, Umakoshi Y, Takahashi J, Matsuura N. Angiogenic activity of osteopontin-derived peptide SVVYGLR. Biochem Biophys Res Commun 2003, 310:153-157. 10.1016/j.bbrc.2003.09.001, 14511663.
13. Hamada Y, Yuki K, Okazaki M, Fujitani W, Matsumoto T, Hashida MK, Harutsugu K, Nokihara K, Daito M, Matsuura N, Takahashi J. Osteopontin-derived peptide SVVYGLR induces angiogenesis in vivo. Dent Mater J 2004, 23:650-655.
14. Hamada Y, Egusa H, Kaneda Y, Hirata I, Kawaguchi N, Hirao T, Matsumoto T, Yao M, Daito K, Suzuki M, Yatani H, Daito M, Okazaki M, Matsuura N. Synthetic osteopontin-derived peptide SVVYGLR can induce neovascularization in artificial bone marrow scaffold biomaterials. Dent Mater J 2007, 26:487-492. 10.4012/dmj.26.487, 17886451.
15. Saito A, Suzuki Y, Kitamura M, Ogata S, Yoshihara Y, Masuda S, Ohtsuki C, Tanihara M. Repair of 20-mm long rabbit radial bone defects using BMP-derived peptide combined with an alpha-tricalcium phosphate scaffold. J Biomed Mater Res A 2006, 77:700-706.
16. Saito A, Suzuki Y, Ogata S, Ohtsuki C, Tanihara M. Activation of osteo-progenitor cells by a novel synthetic peptide derived from the bone morphogenetic protein-2 knuckle epitope. Biochim Biophys Acta 2003, 1651:60-67.
17. Streuli CH, Akhtar N. Signal co-operation between integrins and other receptor systems. Biochem J 2009, 418:491-506. 10.1042/BJ20081948, 19228122.
18. Bokhari MA, Akay G, Zhang S, Birch MA. The enhancement of osteoblast growth and differentiation in vitro on a peptide hydrogel - PolyHIPE Polymer hybrid material. Biomaterials 2005, 26:5198-5520. 10.1016/j.biomaterials.2005.01.040, 15792547.
19. Kirmizidis G, Birch MA. Microfabricated Grooved Substrates Influence Cell-Cell Communication and Osteoblast Differentiation In Vitro. Tissue Eng Part A 2009, 15:1427-1436. 10.1089/ten.tea.2008.0137, 19061431.
20. Place ES, Evans ND, Stevens MM. Complexity in biomaterials for tissue engineering. Nat Mater 2009, 8:457-470. 10.1038/nmat2441, 19458646.
21. Lallier TE, Yukna R, Moses RL. Extracellular matrix molecules improve periodontal ligament cell adhesion to anorganic bone matrix. J Dent Res 2001, 80:1748-1752. 10.1177/00220345010800081301, 11669487.
22. Rao H, Lu G, Kajiya H, Garcia-Palacios V, Kurihara N, Anderson J, Patrene K, Sheppard D, Blair HC, Windle JJ, Choi SJ, Roodman GD. Alpha9beta1: a novel osteoclast integrin that regulates osteoclast formation and function. J Bone Miner Res 2006, 21:1657-1665. 10.1359/jbmr.060718, 1937336, 16995821.
23. Irvine DJ, Ruzette AV, Mayes AM, Griffith LG. Nanoscale clustering of RGD peptides at surfaces using comb polymers. 2. Surface segregation of comb polymers in polylactide. Biomacromolecules 2001, 2:545-556. 10.1021/bm015510f, 11749219.
24. Koo LY, Irvine DJ, Mayes AM, Lauffenburger DA, Griffith LG. Co-regulation of cell adhesion by nanoscale RGD organization and mechanical stimulus. J Cell Sci 2002, 115:1423-1433.
25. Arnold M, Cavalcanti-Adam EA, Glass R, Blümmel J, Eck W, Kantlehner M, Kessler H, Spatz JP. Activation of integrin function by nanopatterned adhesive interfaces. Chemphyschem 2004, 5:383-388. 10.1002/cphc.200301014, 15067875.
26. Takeuchi Y, Suzawa M, Kikuchi T, Nishida E, Fujita T, Matsumoto T. Differentiation and transforming growth factor-β receptor down-regulation by collagen-α2β1 integrin interaction is mediated by focal adhesion kinase and its downstream signals in murine osteoblastic cells. J Biol Chem 1997, 272:29309-29316. 10.1074/jbc.272.46.29309, 9361011.
27. Pallu S, Bareille R, Dard M, Kessler H, Jonczyk A, Vernizeau M, Amédée-Vilamitjana J. A cyclo peptide activates signaling events and promotes growth and the production of the bone matrix. Peptides 2003, 24:1349-1357. 10.1016/j.peptides.2003.09.003, 14706549.
28. Jikko A, Harris SE, Chen D, Mendrick DL, Damsky CH. Collagen integrin receptors regulate early osteoblast differentiation induced by BMP-2. J Bone Miner Res 1999, 14:1075-1083. 10.1359/jbmr.1999.14.7.1075, 10404007.
29. Lai C-F, Cheng S-L. αvβ integrins play an essential role in BMP-2 induction of osteoblast differentiation. J Bone Miner Res 2005, 20:330-340. 10.1359/JBMR.041013, 15647827.
30. Marquis ME, Lord E, Bergeron E, Bourgoin L, Faucheux N. Short-term effects of adhesion peptides on the responses of preosteoblasts to pBMP-9. Biomaterials 2008, 29:1005-1016. 10.1016/j.biomaterials.2007.10.047, 18023475.
31. Tamura Y, Takeuchi Y, Suzawa M, Fukumoto S, Kato M, Miyazono K, Fujita T. Focal adhesion kinase activity is required for bone morphogenetic protein--Smad1 signaling and osteoblastic differentiation in murine MC3T3-E1 cells. J Bone Miner Res 2001, 16:1772-1779. 10.1359/jbmr.2001.16.10.1772, 11585340.
32. Wiemann M, Jennissen HP, Rumpf H, Winkler L, Chatzinikolaidou M, Schmitz I, Bingmann D. A reporter-cell assay for the detection of BMP-2 immobilized on porous and nonporous materials. J Biomed Mater Res 2002, 62:119-127. 10.1002/jbm.10251, 12124793.
33. Matsuzaka K, Yoshinari M, Kokubu E, Shimono M, Inoue T. Behavior of osteoblast-like cells on Fibronectin or BMP-2 immobilized surface. iomed Res 2004, 25:B263-268.
34. Gilboa L, Nohe A, Geissendorfer T, Sebald W, Henis YI, Knaus P. Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors. Mol Biol Cell 2000, 11:1023-1035. 14828, 10712517.
35. Nohe A, Keating E, Underhill TM, Knaus P, Petersen NO. Effect of the distribution and clustering of the type I A BMP receptor (ALK3) with the type II BMP receptor on the activation of signalling pathways. J Cell Sci 2003, 116:3277-3284. 10.1242/jcs.00519, 12829744.
36. Hartung A, Bitton-Worms K, Rechtman MM, Wenzel V, Borgermann JH, Hassel S, Henis YI, Knaus P. Different routes of BMP receptor endocytosis influence BMP signaling. Mol Cell Biol 2006, 26:7791-7805. 10.1128/MCB.00022-06, 1636853, 16923969.
37. Singhatanadgit W, Mordan N, Salih V, Olsen I. Changes in bone morphogenetic protein receptor-IB localisation regulate osteogenic responses of human bone cells to bone morphogenetic protein-2. Int J Biochem Cell Biol 2008, 40:2854-2864. 10.1016/j.biocel.2008.06.005, 18619554.
38. Tsujigiwa H, Nagatsuka H, Lee YJ, Han PP, Gunduz M, Legeros RZ, Inoue M, Yamada M, Nagai N. Immobilized rhBMP-2/succinylated type I atelocollagen gene expression of intracellular signaling molecules on ST2 cells. J Biomed Mater Res A 2006, 77:507-511.
39. Yamachika E, Tsujigiwa H, Shirasu N, Ueno T, Sakata Y, Fukunaga J, Mizukawa N, Yamada M, Sugahara T. Immobilized recombinant human bone morphogenetic protein-2 enhances the phosphorylation of receptor-activated Smads. J Biomed Mater Res A 2009, 88:599-607.
40. Winkler L, Bingmann D, Wiemann M. Heat treatment of BMP-2 depots on implant materials generates an immobilized layer of BMP-2 with pronounced bioactivity. J Biomed Mater Res A 2006, 79:895-901.
41. Lim TY, Wang W, Shi Z, Poh CK, Neoh KG. Human bone marrow-derived mesenchymal stem cells and osteoblast differentiation on titanium with surface-grafted chitosan and immobilized bone morphogenetic protein-2. J Mater Sci Mater Med 2009, 20:1-10. 10.1007/s10856-008-3528-9, 18651113.
42. Falconnet D, Csucs G, Grandin HM, Textor M. Surface engineering approaches to micropattern surfaces for cell-based assays. Biomaterials 2006, 27:3044-3063. 10.1016/j.biomaterials.2005.12.024, 16458351.
43. Phillippi JA, Miller E, Weiss L, Huard J, Waggoner A, Campbell P. Microenvironments engineered by inkjet bioprinting spatially direct adult stem cells toward muscle- and bone-like subpopulations. Stem Cells 2008, 26:127-134. 10.1634/stemcells.2007-0520, 17901398.
44. Kusanagi K, Inoue H, Ishidou Y, Mishima HK, Kawabata M, Miyazono K. Characterization of a bone morphogenetic protein-responsive Smad-binding element. Mol Biol Cell 2000, 11:555-565. 14793, 10679014.